1.Longterm Follow-up after Endoscopic Variceal Ligation for Esophageal Varices.
Ok Jae LEE ; Young Chai KIM ; Jung Ryeol KIM
Korean Journal of Gastrointestinal Endoscopy 1995;15(3):427-736
Endoscopic variceal ligation is an accepted new form of safe treatment for esophageal varices. But, there are a few reports of long-term effect of EVL. We analysed 60 patients to evaluate long-term effect of EVL for esophageal varices. The eradication rate was 96.5%, the mean session for eradication of varices 3.0, the number of bands per person 21.5 and the number of bands per session 7.2, Child-Pugh classes(A: B: C) of patients were improved in 25, not changed in 30, deteriorated in 2 cases by EVL(34:19:4 at postEVL vs 20:19:21 at baseline, p<0.01). No serious treatment-related complication resulted from 167 EVL sessions. The patients were followed for a mean of 10.5 months, during which recurrence rate of varices was 14.5%, rebleeding rate 16.4%, and mortality rate 12,7%. The period from last session to recurrence was 4-19 months(mean 9.6). No late complication of EVL was documented. In conclusion, EVL is a safe and effective for hemostasis and eradication of esophageal varices. Thus it can improve liver function and reduce bleeding-related mortality in patients with liver cirrhosis. But the regular periodic examination for recurrence after an eradication of varices should be required.
Esophageal and Gastric Varices*
;
Follow-Up Studies*
;
Hemostasis
;
Humans
;
Ligation*
;
Liver
;
Liver Cirrhosis
;
Mortality
;
Recurrence
;
Varicose Veins
2.Longterm Follow-up after Endoscopic Variceal Ligation for Esophageal Varices.
Ok Jae LEE ; Young Chai KIM ; Jung Ryeol KIM
Korean Journal of Gastrointestinal Endoscopy 1995;15(3):427-736
Endoscopic variceal ligation is an accepted new form of safe treatment for esophageal varices. But, there are a few reports of long-term effect of EVL. We analysed 60 patients to evaluate long-term effect of EVL for esophageal varices. The eradication rate was 96.5%, the mean session for eradication of varices 3.0, the number of bands per person 21.5 and the number of bands per session 7.2, Child-Pugh classes(A: B: C) of patients were improved in 25, not changed in 30, deteriorated in 2 cases by EVL(34:19:4 at postEVL vs 20:19:21 at baseline, p<0.01). No serious treatment-related complication resulted from 167 EVL sessions. The patients were followed for a mean of 10.5 months, during which recurrence rate of varices was 14.5%, rebleeding rate 16.4%, and mortality rate 12,7%. The period from last session to recurrence was 4-19 months(mean 9.6). No late complication of EVL was documented. In conclusion, EVL is a safe and effective for hemostasis and eradication of esophageal varices. Thus it can improve liver function and reduce bleeding-related mortality in patients with liver cirrhosis. But the regular periodic examination for recurrence after an eradication of varices should be required.
Esophageal and Gastric Varices*
;
Follow-Up Studies*
;
Hemostasis
;
Humans
;
Ligation*
;
Liver
;
Liver Cirrhosis
;
Mortality
;
Recurrence
;
Varicose Veins
3.Geographic double V-osteotomy for the correction of angular deformity of distal humerus.
In KIM ; Seung Koo RHEE ; Sung Soo KIM ; Young Chai LEE
The Journal of the Korean Orthopaedic Association 1991;26(2):469-473
No abstract available.
Congenital Abnormalities*
;
Humerus*
4.Original Articles: Immunogenicity and Safety of a 20 microgram Dose of the Green Cross Recombinant Hepatitis B Vaccine ( HG -II ) in Healthy Adults.
Kye Heui LEE ; Ok Jae LEE ; Young Chai KIM ; Ran NAMGUNG ; Young Mo SOHN
The Korean Journal of Hepatology 1997;3(1):58-64
BACKGROUND/AIMS: The introduction of Hansenula polymorpha for recombinant hepatitis B vaccine production allowed high product yield with plasmid stability and less glycosylation than conventional Saccharomyces cerevisiae system. A Green Cross HG-II vaccine formulated from HBsAg produced by a recombinant strain of the yeast H. polymorpha was evaluated for immunogenicity and safety in an open label triaL METHOFD: A 20 ug dose of Green Cross HG-II vaccine was administered intramuscularly at 0, 1 and 6 months at the deltoid region in 118 healthy adults seronegative for HBV markers. The anti-HBs titers were determined at one month after administration of the third dose of vaccine by radioimmunoassay. RESULTS: The seroconversion rate was 96.8% (90 out of 93), with seroprotective rate of 95.7% (89 out of 93). The geometric mean titers(GMT) of the anti-HBs response was 153.1mIU/ml in seroconverters. An age-dependent effect was observed in the anti-HBs response. But sex-dependent effect was not prominent. Reactogenecity was in incidence and general reactions were short-lasting and a mainly mild in severity. CONCLUSIONS: The results of this study have shown that the Green Cross HG-II vaccine is safe and clinically well tolerated, a nd that it may provide protection against HBV infection.
Adult*
;
Glycosylation
;
Hepatitis B Surface Antigens
;
Hepatitis B Vaccines*
;
Hepatitis B*
;
Hepatitis*
;
Humans
;
Incidence
;
Pichia
;
Plasmids
;
Radioimmunoassay
;
Saccharomyces cerevisiae
;
Yeasts
5.Mechanisms of Acinar Cell Deletion in Rat Pancreas Following Experimental Duct Ligation.
Sang Pyo KIM ; Kun Young KWON ; Sang Sook LEE ; Chai Hong CHUNG
Korean Journal of Pathology 1989;23(1):51-64
This study was carried out to investigate the mechanisms of acinar cell deletion, leading to the pancreatic atrophy of rat pancreas after experimental duct ligation. Fifty-seven male Sprague-Dawley rats, maintained on a stock diet, weighing 200 gm, in average, were divided into 2 experimental groups. Group 1. Control group. Six rats. Abdominal cavity was opened and closed without further treatment. Group 2. Fifty-one rats. Animals were treated with partial ligation of the pancratic ducts according to the procedure developed by Hultquist followed by sequential sacrifices at: 1 hour (3 rats), 3 hours (3 rats), 6 hours (6 rast), 12 hours (3 rats) and 24 hours (8 rats); 2 days (8 rats), 3 days (3 rats), 4 days (3 rats) and 5 days (5 rats); 1 week (3 rats), 2 weeks (3 rats) and 8 weeks (3 rats); after partial ligation was extirpated and examined by both light and electron microscopy. The results obtained were as follows: Light microscopically, noted were an interstitial edema and focal necrosis of the pancreatic tissue along with fine vacuolization and depletion of the zymogen granules in the acinar cell cytoplasms and condensation of the acinar cell nucleus. These changes were observed by 2 days after ligation. At about the same time, one can observe the dense body, identified to be apoptotic body, in the acinar cell which were found to be decreased in quantity. By 5 days after ligation, no recognizable acinar cells left in the collagenous stroma except intercalated ducts. Conspicuous stroma except intercalated ducts. Conspicuous stromal hyalinization, thereafter. Electron microscopically (TEM and SEM), nuclear condensation and margination toward the nuclear membrane was noted by 6 hours after duct ligation. By 24 hors sporadic membrane-bounded apoptotic bodies appeared in the acinar cells, the number of which reaching to the peak by 3 days after ligation. These apoptotic bodies were found to be phagocytosed by either intraepithelial mononuclear phagocytes or adjoining acinar cells. It can be concluded, therefore: That orderly remodeling of pancreatic exocrine tissue during atrophy is effected by rapid deletion of acinar cells by apoptosis.
Male
;
Humans
;
Rats
;
Animals
6.Purification of the Protective Antigen from Bacillus anthracis.
Jeung Moon PARK ; Yong Keel CHOI ; Seong Kun CHO ; Young Gyu CHAI ; Seong Joo KIM
Journal of the Korean Society for Microbiology 1998;33(6):589-594
Anthrax toxin consists of three separate proteins, protective antigen (PA), edema factor (EF), and lethal factor (LF). PA binds to the receptor on mammalian cells and facilitates translocation of EF or LF into its cytosol. PA is the primary component of anthrax vaccines. In this study we purified PA from culture filtrates of Bacillus anthracis. The purification involved sequential chromatography through hydroxylapatite, DEAE-Sepharose CL-4B, followed by Mono-Q. The purified PA was judged to be homogeneous on SDS-PAGE, and consisted of a single polypeptide chain with a relative molecular weight of 85,000.
Anthrax
;
Anthrax Vaccines
;
Bacillus anthracis*
;
Bacillus*
;
Chromatography
;
Cytosol
;
Durapatite
;
Edema
;
Electrophoresis, Polyacrylamide Gel
;
Molecular Weight
7.Curative Radiotherapy of Supraglottic Cancer.
The Journal of the Korean Society for Therapeutic Radiology and Oncology 1998;16(2):139-145
PURPOSE: The purpose of this study was to evaluate the efficacy of curative radiotherapy in the management of supraglottic cancer. MATERIALS AND METHODS: Twenty-one patients with squamous cell carcinoma of the supraglottis were treated with radiotherapy at Gyeongsang National University Hospital between 1990 and 1994. Median follow-up period was 36 months and 95% were observed for at least 2 years. RESULTS: Actuarial survival rate at 5 years was 39.3% for 21 patients. The 5-year actuarial survival rate was 75.0% in Stage I, 42.9% in Stage II, 33.3% in Stage III, and 28.6% in Stage IV (p=0.54). The 5-year local control rate was 52.0% for 21 patients. The 5-year local control rate was 75.0% in Stage I, 57.1% in Stage II, 66.7% in Stage III, and 28.6% in Stage IV (p=0.33). Double primary cancer was developed in 3 patients and those were all esophageal cancers. CONCLUSION: In early stage (Stage I and II) supraglottic cancer, curative radiotherapy would be a treatment of choice and surgery would be better to be reserved for salvage of radiotherapy failure. In advanced stage (Stage III and IV), radiotherapy alone is inadequate for curative therapy and combination with surgery should be done in operable patients. This report emphasizes the importance of esophagoscopy and esophagogram at the follow-up of patients with supraglottic cancer.
Carcinoma, Squamous Cell
;
Esophageal Neoplasms
;
Esophagoscopy
;
Follow-Up Studies
;
Humans
;
Radiotherapy*
;
Survival Rate
8.Curative Radiotherapy of Supraglottic Cancer.
The Journal of the Korean Society for Therapeutic Radiology and Oncology 1998;16(2):139-145
PURPOSE: The purpose of this study was to evaluate the efficacy of curative radiotherapy in the management of supraglottic cancer. MATERIALS AND METHODS: Twenty-one patients with squamous cell carcinoma of the supraglottis were treated with radiotherapy at Gyeongsang National University Hospital between 1990 and 1994. Median follow-up period was 36 months and 95% were observed for at least 2 years. RESULTS: Actuarial survival rate at 5 years was 39.3% for 21 patients. The 5-year actuarial survival rate was 75.0% in Stage I, 42.9% in Stage II, 33.3% in Stage III, and 28.6% in Stage IV (p=0.54). The 5-year local control rate was 52.0% for 21 patients. The 5-year local control rate was 75.0% in Stage I, 57.1% in Stage II, 66.7% in Stage III, and 28.6% in Stage IV (p=0.33). Double primary cancer was developed in 3 patients and those were all esophageal cancers. CONCLUSION: In early stage (Stage I and II) supraglottic cancer, curative radiotherapy would be a treatment of choice and surgery would be better to be reserved for salvage of radiotherapy failure. In advanced stage (Stage III and IV), radiotherapy alone is inadequate for curative therapy and combination with surgery should be done in operable patients. This report emphasizes the importance of esophagoscopy and esophagogram at the follow-up of patients with supraglottic cancer.
Carcinoma, Squamous Cell
;
Esophageal Neoplasms
;
Esophagoscopy
;
Follow-Up Studies
;
Humans
;
Radiotherapy*
;
Survival Rate
9.Chronological observation on intestinal histopathology and intraepithelial lymphocytes in the intestine of rats infected with Metagonimus yokogawai.
Jong Yil CHAI ; Tae Young YUN ; Jin KIM ; Sun HUH ; Min Ho CHOI ; Soon Hyung LEE
The Korean Journal of Parasitology 1994;32(4):215-221
The relationship between the intestinal histopathology and number and position of intraepithelial lymphocytes (IEL) was observed chronologically in the small intestine of rats experimentally infected with Metagonimus yokogawai. Fifteen Sprague-Dawley rats were orally infected each with 3,000 metacecariae, and 3 were kept uninfected for controls. Three rats each were sacrificed on the day 5, 10, 15, 24 and 70 post-infection (PI) and samples of the small intestine, 5 cm, 10 cm, 20 cm and 70 cm posterior to the pylorus were taken. The samples were processed routinely and stained with Giemsa. The intestinal histopathology was severe during the day 5-15 PI and characterized by villous atrophy, crypt hyperplasia, and decrease of villus/crypt height ratio. After the day 24 PI, the intestinal lesions showed some tendency of recovery. The number of IEL increased at the early stage of infection, but decreased thereafter to a lower level than that of controls, with progression of the pathological changes. Then, the IEL number began to increase again after the day 24 PI. In control rats, the great majority of the IEL were located at the basal region of the epithelium. During the early stage of infection, however, a considerable proportion of IEL was found to have moved to the intermediate or apical region of the epithelium. From the above results, it is suggested that the change of IEL number and position during the course of M. yokogawai infection should be closely related to the progression and recovery of the intestinal histopathology.
English-Abstract
;
Epithelium-pathology
;
Rats-
;
Rats,-Sprague-Dawley
;
Time-Factors
;
*Heterophyidae-
;
*Intestinal-Diseases,-Parasitic-pathology
;
*Intestines-pathology
;
*Lymphocytes-pathology
;
*Trematode-Infections-pathology
10.Carcinosarcoma of the gallbladder: Report of a case.
Sun Young KIM ; Sang Sook LEE ; Jong Min CHAE ; Chai Hong CHUNG
Korean Journal of Pathology 1986;20(3):362-368
Carcinosarcoma, often referred to as "malignant mixed tumor" is a rare neoplasm, but this tumor occurs in various organs, including the gallbladder. We report herein a carcinosarcoma of the gallbladder which consisted of adenocarcinomatous and undifferentiated sarcomatous ares, the latter differentiating towards abundant osteoid and calcified but nonlamellated bony trabeculae formation. There are 18 reported cases of this type tumor of the gallbladder in the literature.